Gluskin Sheff & Assoc Inc Hepion Pharmaceuticals, Inc. Transaction History

Gluskin Sheff & Assoc Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.56 - $2.26 $62,400 - $90,399	-40,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.77 - $2.98 $35,400 - $59,600	20,000 Added 100.0%	40,000 $74,000
Q4 2020 Feb 16, 2021	BUY	$1.58 - $3.64 $31,600 - $72,800	20,000 New	20,000 $44,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.